With millions of Americans impacted by diminishing vision and retinal disorders, ophthalmologists are keen to find a restorative solution. Age-related macular degeneration (AMD) is the leading cause of vision loss for older individuals, impacting more than 170 million people across the globe. The number of those impacted by AMD is expected to increase significantly in the next several years, due to our increasing aging of the population.
Retina World Congress (RWC) 2019 will be held from Mar 21 – 24, 2019 at Fort Lauderdale Marriott Harbor Beach Resort & Spa with attendees including retina specialists and other healthcare professionals involved in the treatment of patients with retinal diseases. Retina World Congress is a focused learning initiative uniting international professionals who spearhead innovative solutions and advanced science related to retinal health. In response to the dynamic advances within the retina sub-specialty, the mission of Retina World Congress is to foster ongoing dialogue and generate consensus about retinal diseases, emerging technologies and treatments, best practices, and clinical research.
In an educational session to be held on March 22nd; Dr. Mitul Mehta, MD., co-founder and Chief Medical Officer of Eyedaptic, will present important clinical trial data on a pivotal augmented reality (AR) visual aid, offering life-changing independence to those struggling with age-related macular degeneration (AMD). Dr. Mehta is a Clinical Assistant Professor of Ophthalmology, specializing in medical and surgical diseases of the retina, at UCI’s Gavin Herbert Eye Institute.
The presentation will include key insights from the recent Eyedaptic EYE-01 clinical trial. Efficacy data focused on Timed Instrumental Activities of Daily Life (TIADL) inventory as well as Visual Acuity improvements will be presented. Additionally, use cases supported by usability data from extended in-home usage will also be shared.
Eyedaptic is a privately-held visual aid software company, powered by augmented reality (AR) hardware, designed for AMD and other retinal disorders. The proprietary Simulated Natural Vision software goes beyond magnification to enable a fuller field of vision, key to those with central vision disorders.